scispace - formally typeset
N

Na Kong

Researcher at Brigham and Women's Hospital

Publications -  79
Citations -  6654

Na Kong is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 25, co-authored 54 publications receiving 3568 citations. Previous affiliations of Na Kong include Hangzhou Normal University & Harvard University.

Papers
More filters
Journal ArticleDOI

Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy

TL;DR: This is the first systematic experimental report on the nano-bio interaction of 2D nanomaterials in cells and their application for anti-exocytosis-enhanced synergistic cancer therapy.
Journal ArticleDOI

Phosphorus Science-Oriented Design and Synthesis of Multifunctional Nanomaterials for Biomedical Applications

TL;DR: The phosphorus science to unify current phosphorus-based nanomaterials is introduced and their synthesis methods are discussed and the representative nanoplatforms utilizing the corresponding properties are highlighted.
Journal ArticleDOI

Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition.

TL;DR: Redox-sensitive mRNA nanoparticles help kill tumors by restoring p53 expression by delivering p53-mRNA in nanoparticles and indicate that restoration of tumor suppressors by the synthetic mRNA NP delivery strategy could be combined together with other therapies for potent combinatorial cancer treatment.
Journal ArticleDOI

ROS-Mediated Selective Killing Effect of Black Phosphorus: Mechanistic Understanding and Its Guidance for Safe Biomedical Applications.

TL;DR: It is revealed that the decreased superoxide dismutase (SOD) activity by lipid peroxides could be an essential mechanism of the selectively higher ROS generation induced by BP-based nanosheets in cancer cells.
Journal ArticleDOI

Synthesis of Ultrathin Biotite Nanosheets as an Intelligent Theranostic Platform for Combination Cancer Therapy

TL;DR: An exfoliation approach is provided that combines calcination, n‐butyllithium exchange and intercalation, and liquid exfoliating processes for the high‐yield synthesis of ultrathin BM NSs that allow for multimodal imaging‐guided breast cancer treatment.